N-异丙基-p-[11C]甲基苯丙胺作为新型脑血流PET示踪剂的合成与评价
本研究合成并评价了碳-11标记的N-异丙基-p-[11C]甲基苯丙胺([11C]4)作为新型脑血流(CBF)PET示踪剂。小鼠生物分布显示脑摄取在注射后5-15分钟达峰后迅速下降,脑内放射性主要为原形;在非人灵长类中,[11C]4的K1在对照猴反映区域CBF,但乙酰唑胺负荷后高血流区K1不再反映CBF。结论认为[11C]4是潜在的新型CBF PET示踪剂,尚需进一步验证。
要点
- [11C]4小鼠脑摄取于注射后5-15分钟达峰,随后迅速下降。
- 脑内放射性主要为难变换原形,外周则快速代谢为亲水成分。
- 对照猴中[11C]4的K1反映区域CBF,乙酰唑胺负荷后高血流区不反映。
核心结论
- [11C]4是潜在的新型CBF PET示踪剂,但用于人体前仍需进一步验证研究。
研究设计与样本
- 合成[11C]4并开展小鼠生物分布、外周代谢及非人灵长类PET脑动力学评价,动力学分析采用连续[15O]H2O测量。
主要发现
- 小鼠脑摄取在注射后5-15分钟达峰后迅速下降,脑内放射性大多为未变化形式。
- 外周中[11C]4快速代谢为亲水成分。
- 乙酰唑胺处理显著增加小鼠脑摄取且不影响血放射性水平。
- 初步动力学分析显示对照猴[11C]4的K1反映区域CBF,乙酰唑胺负荷后高血流区K1不反映CBF。
局限性
- 目前仅完成小鼠与非人灵长类的基础生物学与初步动力学评价,尚未在人体中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Increases in fasting plasma glucose (PG) levels lead to a decrease in 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) uptake in the normal brain, especially in the precuneus, resulting in an Alzheimer's disease (AD)-like uptake pattern. Therefore, patients with higher PG levels, such as those with diabetes, can be erroneously diagnosed with AD when positron emission tomography (PET) imaging is done using [18F]FDG, due to reduced uptake of [18F]FDG in the precuneus. To help avoid an erroneous diagnosis of AD due to differences in glucose metabolism, evaluating cerebral blood flow (CBF) in the brain is useful. However, current techniques such as single photon emission computed tomography (SPECT) and [15O]H2O PET have limitations regarding early diagnosis of AD because the images they produce are of low resolution. Here, we developed a novel CBF PET tracer that may be more useful than [18F]FDG for diagnosis of AD. METHODS: We synthesized and evaluated N-isopropyl-p-[11C]methylamphetamine ([11C]4) as a carbon-11-labeled analogue of the standard CBF SPECT tracer N-isopropyl-p-[123I]iodoamphetamine. Fundamental biological evaluations such as biodistribution, peripheral metabolism in mice, and brain kinetics of [11C]4 in non-human primates with PET with successive measurement of [15O]H2O were performed. RESULTS: [11C]4 was synthesized by methylation of the corresponding tributyltin precursor (2) with [11C]MeI in a palladium-promoted Stille cross-coupling reaction. The brain uptake of [11C]4 in mice peaked at 5-15 min after injection and then promptly decreased. Most radioactivity in the brain was detected in the unchanged form, although in the periphery, [11C]4 was rapidly metabolized to hydrophilic components. Acetazolamide (AZM) treatment significantly increased the brain uptake of [11C]4 without affecting the blood levels of radioactivity in mice. Preliminary kinetics analysis showed that the K1 of [11C]4 reflected regional CBF in a vehicle-treated monkey, but that the K1 did not reflect CBF in higher flow regions after AZM loading. CONCLUSION: [11C]4 is a potential novel CBF PET tracer. Further validation studies are needed before [11C]4 can be used in humans.
引用
- Toyohara J, Harada N, Kakiuchi T, et al. Synthesis and evaluation of N-isopropyl-p-[11C]methylamphetamine as a novel cerebral blood flow tracer for positron emission tomography. EJNMMI Res. 2020. PMID: 33000345. doi:10.1186/s13550-020-00702-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。